Translate

Metabolic Disorders Research on Global Antiemetic Drug Top Market Review and Current Demand 2017-2021

"Global Antiemetic Drug Market 2017-2021" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
. .
Description-
' '
-- About Antiemetic Drug
Emesis is defined as forceful expulsion of stomach content either due to humoral stimulation due to chemoreceptor trigger zone (CRTZ) or neural stimulation of emetic centers. The various drugs that are used to treat this condition of emesis are known as antiemetics. The various classes of drug available for management of emesis are serotonin antagonist, dopamine antagonist, NK1 receptor antagonist, antihistaminic, steroids, and anticholinergic. The various applications of antiemetic drugs include chemotherapy, surgery, gastroenteritis, morning sickness, motion sickness, stress-induced emesis, and drugs-induced emesis. This market is primarily volume driven as majority of drugs are available in generic form.
. .
' '
Technavios analysts forecast the global antiemetic drug market to grow at a CAGR of 6.13% during the period 2017-2021.
-- Covered in this report
The report covers the present scenario and the growth prospects of the global antiemetic drug market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.
-- The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Antiemetic Drug Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
-- Key vendors
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi

-- Other prominent vendors
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical

-- Market driver
Increased prevalence of cancer
For a full, detailed list, view our report
-- Market challenge
Lack of animal models
For a full, detailed list, view our report
-- Market trend
Inorganic growth strategies
For a full, detailed list, view our report
-- Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
. .

Comments